243 related articles for article (PubMed ID: 36702141)
1. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
7. Cost-Utility Analysis of Screening for Diabetic Retinopathy in China.
Zhang Y; Bai W; Li R; Du Y; Sun R; Li T; Kang H; Yang Z; Tang J; Wang N; Liu H
Health Data Sci; 2022; 2022():9832185. PubMed ID: 38487485
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China.
Wu X; Wu Y; Tu Z; Cao Z; Xu M; Xiang Y; Lin D; Jin L; Zhao L; Zhang Y; Liu Y; Yan P; Hu W; Liu J; Liu L; Wang X; Wang R; Chen J; Xiao W; Shang Y; Xie P; Wang D; Zhang X; Dongye M; Wang C; Ting DSW; Liu Y; Pan R; Lin H
Nat Commun; 2024 Apr; 15(1):3650. PubMed ID: 38688925
[TBL] [Abstract][Full Text] [Related]
9. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
Xiao X; Xue L; Ye L; Li H; He Y
BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
11. Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults.
Sharafeldin N; Kawaguchi A; Sundaram A; Campbell S; Rudnisky C; Weis E; Tennant MTS; Damji KF
Br J Ophthalmol; 2018 Nov; 102(11):1485-1491. PubMed ID: 29680803
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.
Morrison SL; Dukhovny D; Chan RVP; Chiang MF; Campbell JP
JAMA Ophthalmol; 2022 Apr; 140(4):401-409. PubMed ID: 35297945
[TBL] [Abstract][Full Text] [Related]
13. The Cost-Effectiveness Analysis of Teleglaucoma Screening Device.
Thomas S; Hodge W; Malvankar-Mehta M
PLoS One; 2015; 10(9):e0137913. PubMed ID: 26382956
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China.
Li R; Zhang K; Lu Z; Mou D; Wang J; Li H; Fan S; Wang N; Liu H
BMJ Open; 2023 Sep; 13(9):e073219. PubMed ID: 37673456
[TBL] [Abstract][Full Text] [Related]
15. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China.
Shen M; Zou Z; Bao H; Fairley CK; Canfell K; Ong JJ; Hocking J; Chow EPF; Zhuang G; Wang L; Zhang L
Lancet Reg Health West Pac; 2023 May; 34():100726. PubMed ID: 37283979
[TBL] [Abstract][Full Text] [Related]
17. [Health economic evaluation of telemedicine diabetic retinopathy examination using a non-mydriatic fundus camera in China].
Fan JX; Zhang M; Zhao WY; Han Y; Hu WT; Jia HX; Sun XD
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):919-929. PubMed ID: 37936360
[No Abstract] [Full Text] [Related]
18. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
19. Implementing a digital comprehensive myopia prevention and control strategy for children and adolescents in China: a cost-effectiveness analysis.
Li R; Zhang K; Li SM; Zhang Y; Tian J; Lu Z; Li H; Wang L; Wan X; Zhang F; Li L; Jin ZB; Wang N; Liu H
Lancet Reg Health West Pac; 2023 Sep; 38():100837. PubMed ID: 37520278
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
